Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Antisense oligonucleotide targeting the F508delta mutation of CFTR

EU orphan designation number: EU/3/13/1195   
Active ingredient: Antisense oligonucleotide targeting the F508delta mutation of CFTR
Indication: Treatment of cystic fibrosis
Sponsor: ProQR Therapeutics BV
Darwinweg 24, 2333 CR Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Centralised Orphan - Designation EMA/OD/096/13 (2013)6740 of 07/10/2013